Home / Compounds / CJC-1295 with DAC

CJC-1295 with DAC

GH Optimization

Sustained GH elevation with less frequent dosing.

WADA Status
WADA Banned
Standard Dose
1mg - 2mg
Frequency
1-2x weekly
Half-Life
6-8 days

Athletic Mechanism of Action

Long-acting GHRH analog with a Drug Affinity Complex that binds albumin, extending half-life to 6-8 days for sustained GH elevation.

For athletes, the primary value of CJC-1295 with DAC lies in its ability to sustained gh elevation with less frequent dosing.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.

Recovery Timeline

Variable — onset typically within 2–8 weeks depending on protocol and individual response.

Individual response varies based on injury severity, training load, and baseline health markers.

WADA Compliance Status

WADA Banned Compounded

Blunted GH pulse pattern vs. No DAC. Some prefer pulsatile release.

Always verify current WADA status with your sport's governing body before use in competition.

Research Evidence

Primary Study

https://pubmed.ncbi.nlm.nih.gov/16352683/

Clinical Protocol

Start a CJC-1295 with DAC Protocol

Hatter Labs provides physician-supervised performance protocols with GMP-certified CJC-1295 with DAC and comprehensive biomarker monitoring.

Get Protocol
Physician-Supervised Performance

Start Your Performance Protocol for CJC-1295 with DAC

Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.

HIPAA Compliant · GMP Certified · Physician Supervised